The Compatibility of Astragali Radix and Angelicae Sinensis Radix Attenuates Atherosclerosis by Suppressing Vascular Endothelial PANoptosis via the p38 MAPK/p53 Pathway: A Multi-Omics and Experimental Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188330 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Wanyu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Hunan Provincial for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, C…. Hauptthemen laut MEDLINE: p38 Mitogen-Activated Protein Kinases, Drugs, Chinese Herbal, Atherosclerosis, Angelica sinensis. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Science and Technology Innovation Leading Talent Program, Hunan Provincial Natural Science Universities Joint Fund Project.
Abstract (Originalsprache)
Previous studies have reported that the combination of Astragali Radix and Angelicae Sinensis Radix (AR-ASR) can ameliorate atherosclerosis (AS) through anti-inflammatory effects; however, the exact mechanistic underpinnings still await further clarification. The present study investigates the anti-atherosclerotic action of AR-ASR from the perspective of PANoptosis (encompassing apoptosis, pyroptosis, and necroptosis). To ascertain the chief active ingredients of the AR plus ASR mixture, UPLC-MS/MS detection was utilized. To predict potential therapeutic targets, a multi-faceted bioinformatics strategy was applied, integrating transcriptomics, single-cell sequencing, network pharmacology, molecular docking, and molecular dynamics simulations. In vivo, male ApoE-deficient mice were allocated at random into the model cohort, AR-ASR low-, medium-, and high-dose groups (AR-ASR L, AR-ASR M, and AR-ASR H, respectively), atorvastatin group (ATV), and control group (age-matched wild-type C57BL/6J mice). Atherosclerosis was induced by 12 weeks of high-fat diet feeding, followed by 4 weeks of oral gavage treatment. Assessment parameters included aortic intimal hyperplasia thickness, serum lipid levels, vascular inflammatory factor expression, endothelial function, and the gene and protein expression levels of PANoptosis- and p38MAPK/p53 signaling pathway-related molecules. For in vitro experiments, POVPC-stimulated AVECs were used as an oxidative damage model and then treated with AR-ASR-containing serum. Cell proliferation activity, cell injury rate, and the expression levels of PANoptosis markers and p38MAPK/p53 signaling pathway-related molecules were measured. Furthermore, in the presence of a p38MAPK agonist, the protective effect of AR-ASR on AVECs and its underlying mechanism were investigated. Bioinformatics analysis suggested that AR-ASR modulates PANoptosis and interferes with AS via the p38MAPK/p53 signaling axis. In vivo, AR-ASR treatment reduced serum lipid levels, attenuated aortic intimal hyperplasia, decreased plasma inflammatory cytokine levels and vascular inflammatory factor expression, improved endothelial function, and suppressed both vascular PANoptosis and p38MAPK/p53 pathway activation. In vitro, POVPC induced oxidative damage and PANoptosis in AVECs. AR-ASR-containing serum promoted AVEC viability, reduced LDH release, inhibited the expression of PANoptosis-related markers, and downregulated p38MAPK/p53 signaling pathway protein expression. Furthermore, in the presence of a p38MAPK agonist, the inhibitory effects of AR-ASR on cellular PANoptosis and p38MAPK/p53 pathway activation were significantly attenuated. The AR-ASR compatibility suppresses p38MAPK/p53 pathway activation, thereby inhibiting vascular endothelial PANoptosis-driven inflammatory responses and ameliorating atherosclerotic vascular pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Hunan Provincial for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Chinese and Western Medicine, Hunan University of…
ORCID-Profile: Wei Zhang
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Science and Technology Innovation Leading Talent Program
- Hunan Provincial Natural Science Universities Joint Fund Project
Zitieren
APA
Li, W., Long, Q., Fu, X., Li, Y., Ma, L., Tan, W., Hu, Z., Zhang, Y., She, Y., Zhang, W., & Deng, C. (2026). The Compatibility of Astragali Radix and Angelicae Sinensis Radix Attenuates Atherosclerosis by Suppressing Vascular Endothelial PANoptosis via the p38 MAPK/p53 Pathway: A Multi-Omics and Experimental Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188330
Vancouver
Li W, Long Q, Fu X, Li Y, Ma L, Tan W, et al. The Compatibility of Astragali Radix and Angelicae Sinensis Radix Attenuates Atherosclerosis by Suppressing Vascular Endothelial PANoptosis via the p38 MAPK/p53 Pathway: A Multi-Omics and Experimental Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188330
BibTeX
@article{Li2026,
author = {Li, Wanyu and Long, Qingyin and Fu, Xinying and Li, Yanling and Ma, Lu and Tan, Wei and Hu, Zhongji and Zhang, Yanyan and She, Yan and Zhang, Wei and Deng, Changqing},
title = {The Compatibility of Astragali Radix and Angelicae Sinensis Radix Attenuates Atherosclerosis by Suppressing Vascular Endothelial PANoptosis via the p38 MAPK/p53 Pathway: A Multi-Omics and Experimental Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188330}
}
EUVIMED